Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage

- Steffans Reinhardt, Luiza, Zhang, Xiajie, Groen, Kira, Morten, Brianna C., De Iuliis, Geoffry N., Braithwaite, Antony W., Bourdon, Jean-Christophe, Avery-Kiejda, Kelly A.

Effect of p53 and its N-terminally truncated isoform, Δ40p53, on breast cancer migration and invasion

- Zhang, Xiajie, Groen, Kira, Morten, Brianna C., Reinhardt, Luiza Steffens, Campbell, Hamish G., Braithwaite, Antony W., Bourdon, Jean-Christophe, Avery-Kiejda, Kelly A.

Intronic TP53 polymorphisms are associated with increased Δ133TP53 transcript, immune infiltration and cancer risk

- Eiholzer, Ramona A., Mehta, Sunali, Kazantseva, Marina, Drummond, Catherine J., McKinney, Cushla, Young, Katie, Slater, David, Morten, Brianna C., Avery-Kiejda, Kelly A., Lasham, Annette, Fleming, Nicholas, Morrin, Helen R., Reader, Karen, Royds, Janice A., Landmann, Michael, Petrich, Simone, Reddel, Roger, Huschtscha, Lily, Taha, Ahmad, Hung, Noelyn A., Slatter, Tania L., Braithwaite, Antony W.

Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes

- Mehta, Sunali Y., Morten, Brianna C., Print, Cristin G., Braithwaite, Antony W., Antony, Jisha, Henderson, Luke, Lasham, Annette, Campbell, Hamish, Cunliffe, Heather, Horsfield, Julia A., Reddel, Roger R., Avery-Kiejda, Kelly A.

The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cells

- Joshi, Sanket, Perera, Swetha, Chircop, Megan, Gilbert, Jayne, Smith, Charlotte M., Mariana, Anna, Gordon, Christopher P., Sakoff, Jennette A., McCluskey, Adam, Robinson, Phillip J., Braithwaite, Antony W.